Mental illness, substance use, and cardiovascular disease: Unravelling causal relationships
This project aims to clarify the bidirectional relationships between serious mental illness and its comorbidities using innovative epidemiological methods to enhance prevention and treatment strategies.
Projectdetails
Introduction
Serious mental illness—depression, bipolar disorder, and psychotic disorder—is among the leading causes of disability worldwide, disproportionately affecting people of non-European ancestry. On top of the burden posed by its symptoms, mental illness is also associated with comorbid health problems.
Comorbidities of Mental Illness
The two most important comorbidities of mental illness, given their driving role in decreasing quality and duration of life, are:
- Substance (mis)use
- Cardiovascular disease
Whether these comorbidities arise due to causal relationships is surprisingly unclear. The causal direction is also uncertain: does mental illness lead to comorbidities, and/or do comorbidities increase the risk of (more severe) mental illness?
Expertise and Project Goals
Through several prestigious fellowships, I have established myself as an expert in epidemiological and genetic causal inference methods. In this ambitious project, I will bring together innovative approaches to unravel the relationships of mental illness with substance (mis)use and cardiovascular disease.
My aims are to:
- Assess bidirectional relationships between mental illness and its comorbidities by conducting longitudinal analyses in (multi-ancestry) prospective cohort studies.
- Distinguish bidirectional relationships from shared genetic liability by jointly modelling the complete genetic architecture of mental illness and its comorbidities (genomic structural equation modelling).
- Establish causality by using only highly significant genetic variants as instruments for one variable and testing causal effects on another (Mendelian randomization).
- Fully unravel the nature of relationships between mental illness and its comorbidities by triangulating evidence from aims 1 to 3.
- Assess how informing medical doctors about the outcomes of aim 4 influences their clinical decisions in a randomized online experiment.
Conclusion
This interdisciplinary project sets the stage for more effective prevention and treatment of mental illness across ancestry groups.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.500.000 |
Totale projectbegroting | € 1.500.000 |
Tijdlijn
Startdatum | 1-4-2023 |
Einddatum | 31-3-2028 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- STICHTING AMSTERDAM UMCpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Effects of mental disorders on the wellbeing and prosperity of family members and friendsThis project investigates the impact of mental disorders on the wellbeing of family members and partners using comprehensive Finnish data to inform strategies for reducing societal effects. | ERC Starting... | € 1.499.494 | 2022 | Details |
Environment-Mediated Genetics: The Power of Biological Non-Determinism for Mental HealthThe EM-POWER project aims to uncover how modifiable social and lifestyle factors mediate genetic influences on brain and mental health, promoting a non-deterministic view of biology and personal agency. | ERC Consolid... | € 1.997.169 | 2025 | Details |
New molecular understanding of mental disorders through deep cerebrospinal fluid phenotypingThis project aims to revolutionize psychiatry by conducting unprecedented deep phenotyping of cerebrospinal fluid to identify novel therapeutic targets and enhance understanding of mental disorders. | ERC Starting... | € 1.499.070 | 2024 | Details |
Disentangling psychological interventions for mental disorders into a taxonomy of active ingredientsThis project aims to enhance treatment efficacy for severe mental disorders by analyzing psychological interventions' components, creating a taxonomy, and developing a decision support system for personalized care. | ERC Starting... | € 1.497.500 | 2022 | Details |
Unveiling the Molecular Secrets of Reproductive Mood Disorders: a Multi-Omics Approach ProjectThe MoodMAP project aims to identify molecular markers and biological factors of reproductive mood disorders to improve diagnosis, prevention, and treatment strategies for women's mental health. | ERC Starting... | € 1.499.999 | 2025 | Details |
Effects of mental disorders on the wellbeing and prosperity of family members and friends
This project investigates the impact of mental disorders on the wellbeing of family members and partners using comprehensive Finnish data to inform strategies for reducing societal effects.
Environment-Mediated Genetics: The Power of Biological Non-Determinism for Mental Health
The EM-POWER project aims to uncover how modifiable social and lifestyle factors mediate genetic influences on brain and mental health, promoting a non-deterministic view of biology and personal agency.
New molecular understanding of mental disorders through deep cerebrospinal fluid phenotyping
This project aims to revolutionize psychiatry by conducting unprecedented deep phenotyping of cerebrospinal fluid to identify novel therapeutic targets and enhance understanding of mental disorders.
Disentangling psychological interventions for mental disorders into a taxonomy of active ingredients
This project aims to enhance treatment efficacy for severe mental disorders by analyzing psychological interventions' components, creating a taxonomy, and developing a decision support system for personalized care.
Unveiling the Molecular Secrets of Reproductive Mood Disorders: a Multi-Omics Approach Project
The MoodMAP project aims to identify molecular markers and biological factors of reproductive mood disorders to improve diagnosis, prevention, and treatment strategies for women's mental health.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A Multi-Omics Approach for Novel Drug Targets, Biomarkers and Risk Algorithms for Myocardial InfarctionTargetMI aims to rapidly discover novel drug targets and biomarkers for myocardial infarction using a high-throughput multi-omic approach on 1000 samples, enhancing clinical risk prediction and translation. | EIC Pathfinder | € 3.999.840 | 2023 | Details |
A Multi-Omics Approach for Novel Drug Targets, Biomarkers and Risk Algorithms for Myocardial Infarction
TargetMI aims to rapidly discover novel drug targets and biomarkers for myocardial infarction using a high-throughput multi-omic approach on 1000 samples, enhancing clinical risk prediction and translation.